|
楼主 |
发表于 2008-12-10 09:49:59
|
显示全部楼层
69-9-第九节 预 后
一、GCA复发以及治疗失败的定义
5 J. ^% q+ i; {8 I4 @8 D6 o5 V7 p+ K, x9 E
GCA复发:GCA复发是指ESR由正常升至)40 mm/h,加上以下GCA的特点中的至少一项,这些表现有GCA引起而非其他疾病所致。这些表现为:①发热,T) 38℃至少一周;②出现PMR;③头痛、头皮痛或触痛;④失明;⑤下领或口周疼痛;⑥肢端间歇运动障碍;⑦与血管炎一致的动脉造影异常;⑧脑缺血或脑梗死;⑨其他证实为GCA特点的表现。
/ Q; E' B* b0 c3 r9 M* {2 S$ N. _& S2 b+ ]* @" `6 o7 P3 Q1 a5 Q
GCA治疗失败:出现2次不同的复发,或使用泼尼松治疗期间出现复发,且较上一有效剂量加大10mg治疗仍不能改善。
8 \ a9 h6 o# H' x5 ^- ~; G7 @
5 I Z0 b0 V. z$ h6 Y6 q0 ~ 二、预后 4 G- U5 S- D7 \; E: ?- l$ K& x% p
, j8 i1 g4 L4 u! Y! d
PMR一般为2年期的自限性疾病,较少发展为GCA。GCA的视力受损通常是不可逆,平均需治疗 2年,部分患者需治疗5年或更多。早期报道GCA合并PMR的老年患者病死率为1% -12%,近年来由于早期诊断和治疗的改善,其病死率和同年龄组常人无差异。
2 }: j: v0 S% {6 G ( 曾小峰 艾脉心 )
1 D% c' a+ l! R! d; B3 K0 o 参考文献:, I+ z Q" M/ _% y8 H; |
/ [! P* b" c9 r6 u4 Z9 y0 `# U8 Z
Airo P, Antonioli CM, Vianelli M, et al. Anti-tumournecrosis factor treatment with infliximab in a case of giant cell at-teritis resistant to steroid and immunosuppressive drugs. Rheuma-tology, 2002. 41:347一349 # L; L2 ^. p. ?" M
& G8 _ y/ _8 r6 I+ `
Alpers CE, Davis CL, Barr D. Identification of platelet-de-rived growth factor A and B chains in human renal vascular rejec-tion. Am J Pathol,1996. 148:439一451
[8 w) t. k( i q9 p6 b& v& w3 a1 D3 @3 g& ]9 |
Bignon JD, Ferec C, Barrier J. HLA class II genes polymor-phism in DR4 giant cell arteritis patients. Tissue Antigens, 1988.32:254一258
% G0 F$ C/ }& u% W, B6 G6 E3 c
! R4 ~9 w* A. B( y Boyev LR, Miller NR, Green WR. Efficacy of unilateralversus bilateral temporal artery biopsies for the diagnosis of giant cellarteritis [see comments].Am J Ophthalmol,1999.128:211一215 6 l3 J+ V7 B$ k6 ], w4 w, t: K% n
* {& ^ W) x, J7 }; J Brack A, Martinez-Taboada V, Stanson A. Disease patternin cranial and large-vessel giant cell arteritis仁see comments ].Arthritis Rheum, 1999. 42:311一317 9 |. C; A- m! i( C# D) c- P4 m
, ?0 i, N& s A" { Cantini F, Salvararni C Olivieri 1, et al. Shoulder ultrasono-graphy in the diagnosis of polymyalgia rheumatica: a case-controlstudy. J Rheumato1,2001.28:1049一1055 , e2 w+ V: T8 C6 {
8 K& S$ M' p. H9 d9 S c Caporali R, Montecucco C, Epis O, et al. Presenting fea-tures of polymyalgia rheumatica (PMR) and rheumatoid arthritiswith PMR-like onset: a prospective study. Ann Rheum Dis,2001.60:1021一1024
- K$ W& \. N: P. K" O* ~/ ^& [3 j# A
Cid MC, Cebrian M, Font C. Cell adhesion molecules in thedevelopment of inflammatory infiltrates in giant cell arteritis: in-flammation- induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions. Arthritis Rheum, 2000.43:184一194 $ w+ E( o* ^0 e3 X% U* a( Z1 C
7 y+ u3 `# v- q: c V
Cohen MD, Ginsburg WW. Polymyalgia rheumatica.Rheum Dis Clin North Am, 1990. 16:325一339 ) k3 Q ~9 `" C% H& Y4 f4 A# n
1 }! j3 ^% {" n& J9 Q
Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C. Giant cellarteritis and polymyalgia rheumatica can be differentiated by dis-tinct patterns of HLA class II association. J Rheumato1,1998. 25:2140一2145 4 T" X9 B: E' @
5 _, k6 I' w- x3 V+ M$ V Ghanchi FD, Dutton GN. Current concepts in giant cell(temporal) arteritis. Surv Ophthalmol,1997.42:99一123
" }0 V9 x4 b- E7 P& \7 s# S- c+ S2 }
Gran JT, Myklebust G, Wilsgaard T, et al. Survival inpolymyalgia rheumatica and temporal arteritis: a study of 398 cas-es and matched population controls. Rheumatology (Oxford),2001.40:1238一1242 2 g& j% o5 F4 k4 V2 q. j& b8 l
1 O- N- z+ P J: N6 M( L
Haworth S, Ridgeway J, Stewart I. Polymyalgia rheumaticais associated with both HLA-DRBI * 0401 and DRBI * 0404. BrJ Rheumatol,1996. 35 :632一635 4 c: T- _5 U9 R& [, e" T
0 k0 j+ y0 X4 W, r9 b# P
Helweg-Larsen J, Tarp B, Obel N, et al. No evidence ofparvovirus B19, Chlamydia pneumoniae or human herpes virus in-fection in temporal artery biopsies in patients with giant cell at eritis. Rheumatology,2002.41:445一449
! ]" H( H8 f5 J) U, Q
) Z+ ]/ Q' \6 i1 b6 K% Y, z. N Hoffman GS, Cid MC, Hellmann DB, et al. A multicenter,randomized, double-blind, placebo-controlled trial of adjuvantmethotrexate treatment for giant cell arteritis. Arthritis Rheum,2002.46:9一18
7 w1 Z4 I' I8 u4 o1 o4 k- S1 z0 i: w6 Q
Hunder GG, Bloch DA, Michel BA, et al. The AmericanCollege of Rheumatology 1990 criteria for the classification of gi-ant cell arteritis. Arthritis Rheum, 1990. 33:1122一1128 & C* Y0 T" V2 N7 m* j2 b
" s! w5 i0 Q- S0 E
Jover JA, Hernandez-Garcia C, Morado IC. Combined treat-ment of giant-cell 2001
! U. E J( T( @3 d- D
! Z# [! m( N- V3 V {, R' X Kaiser M, Weyand CM, Bjornsson J. Platelet-derivedgrowth factor, intimal hyperplasia, and ischemic complications ingiant cell arteritis. Arthritis Rheum, 1998.41:623一633 7 [. X3 S+ J k$ t6 X7 h6 x0 w
) N' Q% k# K" W! }5 W: `
McGonagle D, Pease C, Marzo-Ortega H, et al. Compari-son of extracapsular changes by magnetic resonance imaging in pa-tients with rheumatoid arthritis and polymyalgia rheumatica. JRheumatol, 2001.28:1937一1941
+ ~$ r# q1 T" J) _) o9 |8 L1 @# ]" @8 J& @1 R( j
Meliconi R, Pulsatelli L, Uguccioni M. Leukocyte infiltra-tion in synovial tissue from the shoulder of patients withpolymyalgia rheumatica. Quantitative analysis and influence ofcorticosteroid treatment. Arthritis Rheum, 1996. 39:1199一1207
0 w" T& g$ A( R( p6 {
, {, _. U1 i' h4 ]" r% j Narvaez J, Nolla-Sole JM, Clavaguera MT. Longterm thera-py in polymyalgia rheumatica: effect of coexistent temporal arteri-tis. J Rheumato1,1999.26:1945一1952
4 K8 o! _7 L+ J. L) P P+ }: G! z9 x) j, }6 x
Narvaez J,Nolla-Sole JM, Narvaez JA, et al. Musculoskele-tat manifestations in polymyalgia rheumatica and temporal arteri-tis. Ann Rheum Dis,2001.60:1060一1063 9 r/ F% ~0 R) O
( u& I0 P: }. G" X8 S& X% t1 q Nesher G, Shemesh D, Mates M, et al. The predictive valueof the halo sign in color Doppler ultrasonography of the temporalarteries for diagnosing giant cell arteritis. J Rheumato1,2002.29:1224一1226 ; `+ N, [6 r6 t3 Y8 z+ L
Ray-Chaudhuri N, Kine DA, Tijani SO, et al. Effect of priorsteroid treatment on temporal artery biopsy findings in giant cellarteritis. Br J Ophthalmol,2002. 86:530一532
1 f; ^( L0 `" f3 A* a
: v' f) `: u( a. y; r Salvarani C, Cantini F, Olivieri 1. Proximal bursitis in activepolymyalgia rheumatica. Ann Intern Med,1997. 127:27一31 + H) D8 D4 K9 V+ H! [
! g1 o E0 k }4 h1 g% L) x Schmidt WA, Kraft HE, Vorpahl K. Color duplex ultra-sonography in the diagnosis of temporal arteritis [see comments].N Eng1J Med,1997.337:1336一1342
5 f9 m* M. V/ o: E0 `3 r
' z0 B5 H% [( b% Q0 N Weyand CM, Goronzy JJ. Arterial wall injury in giant cellarteritis. Arthritis Rheum, 1999. 42:844一853 7 U0 B* ]; x- R/ ]* e% G6 I1 I! A
Weyand CM, Hicok KC Hunder y. Tissue cytokine pat-terns in patients with polymyalgia rheumatica and giant cell arteri-tis [see comments],Ann Intern Med,1994.121:484一491 ) G }3 H: {3 S9 ]" t% J
; e) u/ g9 g- t" L4 Y8 v1 I' k* y' Y
Weyand CM, Kaiser M, Yang Hongyu, et al. Therapeuticeffects of acetylsalicylic acid in giant cell arteritis. ArthritisRheum, 2002. 46:457一466 |
|